Endo International Overview
- Year Founded
-
1935
- Status
-
Acquired/Merged
- Employees
-
2,931
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
19
- Investments
-
24
Endo International General Information
Description
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.
Contact Information
Website
www.endo.comCorporate Office
- 9 Great Valley Parkway
- Malvern, PA 19355
- United States
Corporate Office
- 9 Great Valley Parkway
- Malvern, PA 19355
- United States
Endo International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Endo International Comparisons
Industry
Financing
Details
Endo International Competitors (13)
One of Endo International’s 13 competitors is Roche, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Roche | Corporation | Basel, Switzerland | ||||
| Novartis India | Corporation | Mumbai, India | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria |
Endo International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Endo International Patents
Endo International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10285396-B2 | Game tracking device | Active | 03-Jul-2014 | ||
| US-20160000061-A1 | Game tracking device | Active | 03-Jul-2014 | ||
| CA-2905721-A1 | Urethral anastomosis device | Inactive | 14-Mar-2013 | ||
| US-10294212-B2 | Inhibitors of the kynurenine pathway | Active | 14-Mar-2013 | ||
| US-20180030026-A1 | Inhibitors of the kynurenine pathway | Active | 14-Mar-2013 | C07D333/66 |
Endo International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endo International Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Endo International Investments & Acquisitions (24)
Endo International’s most recent deal was a Corporate Asset Purchase with Nevakar Injectables (Six Development Stage -Injectable Product) for . The deal was made on 09-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nevakar Injectables (Six Development Stage -Injectable Product) | 09-May-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Biospecifics Technologies | 01-Dec-2020 | Merger/Acquisition | Pharmaceuticals | ||
| Somerset Pharma | 26-Apr-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Aspen Holdings (branded and generic injectable and established products) | 01-Oct-2015 | Merger/Acquisition | Medical Supplies | ||
| Par Pharmaceutical Companies | 25-Sep-2015 | Merger/Acquisition | Pharmaceuticals |
Endo International Exits (5)
Endo International’s most recent exit was on 24-Jul-2014 from Grupo Farmaceutico Somar. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Grupo Farmaceutico Somar | 24-Jul-2014 | Completed |
|
||
| American Medical Systems | 11-Apr-2011 | Completed |
|
||
| HealthTronics | 15-Jul-2010 | Completed |
|
||
| Endo Pharmaceuticals Solutions | 05-Jan-2009 | Merger/Acquisition | Completed |
Endo International Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Auxilium Pharmaceuticals | Chesterbrook, PA | 1999 | |
| Nascobal | Bothell, WA | 1997 | |
| Paladin Pharma | Saint-Laurent, Canada | 1983 |
Endo International FAQs
-
When was Endo International founded?
Endo International was founded in 1935.
-
Where is Endo International headquartered?
Endo International is headquartered in Malvern, PA.
-
What is the size of Endo International?
Endo International has 2,931 total employees.
-
What industry is Endo International in?
Endo International’s primary industry is Pharmaceuticals.
-
Is Endo International a private or public company?
Endo International is a Private company.
-
What is Endo International’s current revenue?
The current revenue for Endo International is .
-
How much funding has Endo International raised over time?
Endo International has raised $1.5B.
-
Who are Endo International’s investors?
Algos Pharmaceuticals, EIDP, Fidelity Investments, and Kelso & Company have invested in Endo International.
-
Who are Endo International’s competitors?
Roche, Novartis India, Teva Pharmaceutical Industries, AstraZeneca, and GlaxoSmithKline Consumer Nigeria are some of the 13 competitors of Endo International.
-
When was Endo International acquired?
Endo International was acquired on 24-Oct-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
